Nording et al. affirms the inhibition of the functional heterodimer and elaborates upon the CXCL4-CCR5 interaction’s ability to reduce inflammation and atherosclerosis, without impairing immune function [36]. This evidence concerns the gene PF4 and atherosclerosis.